Computer-aided polyp characterization in colonoscopy: sufficient performance or not?Halvorsen N, Mori Y. Clin Endosc. 2024 Jan;57(1):18-23. doi: 10.5946/ce.2023.092. Epub 2024 Jan 5. PMID: 38178329 Free PMC article. Review.
Level 1 Impact Factor 2.1
CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life.
Imperiale TF. Ann Intern Med. 2024 Jan;177(1):JC9. doi: 10.7326/J23-0112. Epub 2024 Jan 2. PMID: 38163373
Bretthauer M, Wieszczy P, Loberg M, et al. Estimated lifetime gained with cancer screening tests: a meta-analysis of randomised clinical trials. ...
Level 2 Journal Impact Factor 19.6
Ideal cardiovascular health and risk of death in a large Swedish cohort.
Ding L, Ponzano M, Grotta A, Adami HO, Xue F, Lagerros YT, Bellocco R, Ye W. BMC Public Health. 2024 Feb 2;24(1):358. doi: 10.1186/s12889-024-17885-4.PMID: 38308327 Free PMC article.
Level 1 Impact Factor 3.5
Potential for Cure by Stage across the Cancer Spectrum in the United States.
Hubbell E, Clarke CA, Smedby KE, Adami HO, Chang ET. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):206-214. doi: 10.1158/1055-9965.EPI-23-1018. PMID: 38019271 Free PMC article.
Level 2 Impact Factor 3.7
Lifetime Gained With Cancer Screening-Reply.
Bretthauer M, Kaminski MF, Kalager M. JAMA Intern Med. 2024 Feb 1;184(2):228. doi: 10.1001/jamainternmed.2023.7067.PMID: 38165695 No abstract available.
Level 2 Journal Impact Factor 22.3
Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.
O'Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, Clendenen TV, D'Aloisio A, DeHart JC, Franceschi S, Freedman ND, Gierach GL, Giles GG, Lacey JV, Lee IM, Liao LM, Linet MS, McCullough ML, Patel AV, Prizment A, Robien K, Sandler DP, Stolzenberg-Solomon R, Weiderpass E, White E, Wolk A, Zheng W, Berrington de Gonzalez A, Kitahara CM. Int J Epidemiol. 2024 Feb 1;53(1):dyad172. doi: 10.1093/ije/dyad172. PMID: 38110618 Free PMC article.
Management of non-curative endoscopic resection of T1 colon cancer.
Bernklev L, Nilsen JA, Augestad KM, Holme Ø, Pilonis ND. Best Pract Res Clin Gastroenterol. 2024 Feb;68:101891. doi: 10.1016/j.bpg.2024.101891. Epub 2024 Feb 21. PMID: 38522886 Free article. Review.
Level 1 Impact Factor 3.2
Multimodal cancer treatment with endoscopy.
Kaminski MF, Pilonis ND. Best Pract Res Clin Gastroenterol. 2024 Feb;68:101892. doi: 10.1016/j.bpg.2024.101892. Epub 2024 Feb 16. PMID: 38522892 No abstract available.
Level 1 Impact Factor 3.2
Endoscopic resection of residual rectal neoplasia after definitive chemoradiotherapy for rectal cancer.
Klimkowski R, Krzyzkowiak J, Pilonis ND, Bujko K, Kaminski MF. Best Pract Res Clin Gastroenterol. 2024 Feb; 68:101896. doi: 10.1016/j.bpg.2024.101896. Epub 2024 Feb 28. PMID: 38522889 Review.
Level 1 Impact Factor 3.2
Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer.
Juul FE, Cross AJ, Schoen RE, Senore C, Pinsky PF, Miller EA, Segnan N, Wooldrage K, Wieszczy-Szczepanik P, Armaroli P, Garborg KK, Adami HO, Hoff G, Kalager M, Bretthauer M, Holme Ø, Løberg M. JAMA Netw Open. 2024 Feb 5;7(2):e240007. doi: 10.1001/jamanetworkopen.2024.0007. PMID: 38421651 Free PMC article. Clinical Trial.
Level 1 Journal Impact Factor 10.5
Incidence of oncogenic HPV infection in women with and without mental illness: A population-based cohort study in Sweden.
Herweijer E, Hu K, Wang J, Lu D, Sparén P, Adami HO, Valdimarsdóttir U, Sundström K, Fang F. PLoS Med. 2024 Mar 25;21(3):e1004372. doi: 10.1371/journal.pmed.1004372. eCollection 2024 Mar. PMID: 38527071 Free PMC article.
Level 2 Impact Factor 10.5
Editorial Tidsskr Nor Laegeforen.2024 Mar 20;144(5).
doi: 10.4045/tidsskr.24.0141. Print 2024 Apr 23.
Scraps of national clinical guidelines from the Directorate of Health
[Article in Norwegian]
Lise M Helsingen, Eline Aurvoll Langeland, Synne Eline Rotihaug Pisani, Per Olav Vandvik, Espen A Haavardsholm, Ulrik Fredrik Malt, Christoph Müller, Andreas Stensvold, Mette Kalager, Michael Bretthauer. PMID: 38651715 DOI: 10.4045/tidsskr.24.0141 Free article
Level 1
Authors' Reply: Interpreting epidemiologic studies of colonoscopy screening for colorectal cancer prevention.
Song M, Bretthauer M. Eur J Epidemiol. 2024 Apr;39(4):431. doi: 10.1007/s10654-023-01077-2. Epub 2024 Jan 23. PMID: 38261147 No abstract available.
Level 2 Journal Impact Factor 7.7
New horizons in polyp size estimation.
Mori Y. Endoscopy. 2024 Apr;56(4):271-272. doi: 10.1055/a-2224-0756. Epub 2024 Jan 12. PMID: 38216131 No abstract available.
Level 2 Journal Impact Factor 11.5
Commentary.
Pilonis N. Endoscopy. 2024 Apr;56(4):316. doi: 10.1055/a-2241-6323. Epub 2024 Mar 28. PMID: 38547876 No abstract available.
Level 2 Journal Impact Factor 11.5
Expert endoscopist assessment of colorectal polyp size using virtual scale endoscopy, visual or snare-based estimation: a prospective video-based study.
Popescu Crainic I, Djinbachian R, Rex DK, Barkun A, Shaukat A, East J, Hassan C, Mori Y, Pohl H, Rastogi A, Sharma P, Anderson JC, Taghiakbari M, Medawar E, von Renteln D. Scand J Gastroenterol. 2024 May;59(5):608-614. doi: 10.1080/00365521.2024.2308519. Epub 2024 Feb 9. PMID: 38333956
Level 1 Journal Impact Factor 1.6
Gastroenterology/Hepatology: What You May Have Missed in 2023.
Anvari S, Dadgar K, Galts C, Bretthauer M. Ann Intern Med. 2024 May;177(5_Supplement): S27-S36. doi: 10.7326/M24-0505. Epub 2024 Apr 16. PMID: 38621241
Level 2 Journal Impact Factor 19.6
How to learn from interval cancers in colorectal cancer screening.
Bretthauer M. Endoscopy. 2024 May;56(5):373-375. doi: 10.1055/a-2279-9932. Epub 2024 Mar 13. PMID: 38479414 No abstract available.
Level 2 Journal Impact Factor 11.5
Computer-Aided Diagnosis for Leaving Colorectal Polyps In Situ : A Systematic Review and Meta-analysis.
Hassan C, Misawa M, Rizkala T, Mori Y, Sultan S, Facciorusso A, Antonelli G, Spadaccini M, Houwen BBSL, Rondonotti E, Patel H, Khalaf K, Li JW, Fernandez GM, Bhandari P, Dekker E, Gross S, Berzin T, Vandvik PO, Correale L, Kudo SE, Sharma P, Rex DK, Repici A, Foroutan F; CADx Analysis Study Group.Ann Intern Med. 2024 Jul;177(7):919-928. doi: 10.7326/M23-2865. Epub 2024 May 21. PMID: 38768453 Review.
Level 2 Journal Impact Factor 19.6
Carbon-Footprint Analyses in RCTs - Toward Sustainable Clinical Practice.
Nordberg LB, Pohl H, Haavardsholm EA, Lillegraven S, Bretthauer M. N Engl J Med. 2024 Jun 27;390(24):2234-2236. doi: 10.1056/NEJMp2402018. Epub 2024 May 15. PMID: 38749030 No abstract available.
Level 2 Journal Impact Factor 96.3
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade.
Ree AH, Høye E, Esbensen Y, Beitnes AR, Negård A, Bernklev L, Tetlie LK, Fretland ÅA, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Nilsen HL, Flatmark K, Meltzer S. Oncoimmunology. 2024 Jun 28;13(1):2372886. doi: 10.1080/2162402X.2024.2372886. eCollection 2024. PMID: 38952672 Free PMC article. Clinical Trial.
Level 1 Impact Factor 6.5.
ESGE and Public Advocacy.
Bretthauer M, Ponchon T. Endoscopy. 2024 Jun;56(6):457-458. doi: 10.1055/a-2277-2204. Epub 2024 May 29. PMID: 38810622 Free article. No abstract available.
Level 2 Journal Impact Factor 11.5
Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers.
Xu H, Bretthauer M, Fang F, Ye W, Yin L, Adami HO. Br J Cancer. 2024 Sep;131(4):747-754. doi: 10.1038/s41416-024-02757-w. Epub 2024 Jun 27. PMID: 38937622 Free PMC article.
Level 2 Journal Impact Factor 6.4
Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis.
Baile-Maxía S, Mangas-Sanjuán C, Ladabaum U, Sánchez-Ardila C, Sala-Miquel N, Hassan C, Rutter MD, Bretthauer M, Zapater P, Jover R. Gastrointest Endosc. 2024 Oct;100(4):605-615.e14. doi: 10.1016/j.gie.2024.05.021. Epub 2024 Jun 6. PMID: 38851458 Free article. Review.
Level 1 Journal Impact Factor 6.7
Impact of inadequate bowel cleansing in sigmoidoscopy screening.
Randel KR, Schult AL, Botteri E, Nawaz M, Nguyen DH, Holme Ø, Bretthauer M, Hoff G, de Lange T. Scand J Gastroenterol. 2024 Aug;59(8):1002-1009. doi: 10.1080/00365521.2024.2364213. Epub 2024 Jun 8. PMID: 38850200 Free article. Clinical Trial.
Level 1 Journal Impact Factor 1.6
Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease.
Iacucci M, Santacroce G, Zammarchi I, Maeda Y, Del Amor R, Meseguer P, Kolawole BB, Chaudhari U, Di Sabatino A, Danese S, Mori Y, Grisan E, Naranjo V, Ghosh S.Lancet Gastroenterol Hepatol. 2024 Aug;9(8):758-772. doi: 10.1016/S2468-1253(24)00053-0. Epub 2024 May 14. PMID: 38759661 Review.
Level 2 Impact Factor 30.9
Nordic Nutrition Recommendations and risk of myocardial infarction and stroke: a prospective cohort study.
Sjöblom L, Hantikainen E, Bellocco R, Ye W, Adami HO, Trolle Lagerros Y, Bonn SE.Eur J Nutr. 2024 Jun;63(4):1151-1162. doi: 10.1007/s00394-024-03337-7. Epub 2024 Feb 14. PMID: 38353704 Free PMC article.
Level 1 Impact Factor 4.1
Traditional septotomy or Z-POEM for Zenker's diverticulum.
Kaminski MF, Budnicka A, Przybysz A, Pilonis ND. Best Pract Res Clin Gastroenterol. 2024 Aug; 71:101943. doi: 10.1016/j.bpg.2024.101943. Epub 2024 Aug 8. PMID: 39209416 Review.
Level 1 Impact Factor 3.2
Brief sigmoidoscopy provides 21-year colorectal cancer risk reduction in men.
Bretthauer M, Pilonis ND. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):777-779. doi: 10.1016/S2468-1253(24)00199-7. Epub 2024 Jul 20. PMID: 39038481 No abstract available.
Level 2 Impact Factor 30.9
Surgical treatment of benign colorectal polyps 2008-21.
Nilsen JA, Bernklev L, Bretthauer M, Kalager M, Jodal HC, Løberg M, Holme Ø, Juul FE, Frigstad SO. Tidsskr Nor Laegeforen. 2024 Sep 4;144(10). doi: 10.4045/tidsskr.23.0722. Print 2024 Sep 10. PMID: 39254026 Free article. English, Norwegian.
Level 1
International consensus on the management of large (≥20 mm) colorectal laterally spreading tumors: World Endoscopy Organization Delphi study.
Djinbachian R, Rex DK, Chiu HM, Fukami N, Aihara H, Bastiaansen BAJ, Bechara R, Bhandari P, Bhatt A, Bourke MJ, Byeon JS, Cardoso D, Chino A, Chiu PWY, Dekker E, Draganov PV, Elkholy S, Emura F, Goldblum J, Haji A, Ho SH, Jung Y, Kawachi H, Khashab M, Khomvilai S, Kim ER, Maselli R, Messmann H, Moons L, Mori Y, Nakanishi Y, Ngamruengphong S, Parra-Blanco A, Pellisé M, Pinto RC, Pioche M, Pohl H, Rastogi A, Repici A, Sethi A, Singh R, Suzuki N, Tanaka S, Vieth M, Yamamoto H, Yang DH, Yokoi C, Saito Y, von Renteln D. Dig Endosc. 2024 Nov;36(11):1253-1268. doi: 10.1111/den.14826. Epub 2024 Jun 27. PMID: 38934243
Level 1 Impact factor 5.0
Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps.
Martínez-Roca A, Cubiella J, García-Heredia A, Guill-Berbegal D, Baile-Maxía S, Mangas-Sanjuán C, Sala-Miquel N, Madero-Velazquez L, Alenda C, Zapater P, González-Núñez C, Iglesias-Gómez A, Codesido-Prado L, Díez-Martín A, Kaminski MF, Erichsen R, Adami HO, Ferlitsch M, Pellisé M, Holme Ø, Dekker E, Bretthauer M, Jover R; EPoS Study Group. United European Gastroenterol J. 2024 Nov;12(9):1179-1189. doi: 10.1002/ueg2.12667. Epub 2024 Oct 13. PMID: 39400528 Free PMC article.
Level 1 Journal Impact Factor 5.8
Adverse events after colonoscopy in a randomised colorectal cancer screening trial.
Rognstad ØB, Botteri E, Hoff G, Bretthauer M, Gulichsen E, Frigstad SO, Holme Ø, Randel KR. BMJ Open Gastroenterol. 2024 Oct 7;11(1):e001471. doi: 10.1136/bmjgast-2024-001471. PMID: 39375173 Free PMC article. Clinical Trial.
Level 1 Journal Impact Factor 3.3
Rette hansker under fødsel gir mindre avfall.
Kalager M, Johannessen KA, Balakumar A, Langeland EA, Mahalingam S, Nilsen M, Safa N. Tidsskr Nor Laegeforen. 2024 Oct 10;144. doi: 10.4045/tidsskr.24.0374. Print 2024 Oct 11. PMID: 39404259 Free article. Norwegian. No abstract available.
Level 1
Pasientjournaler og nasjonale kvalitetsregistre – to sider av samme sak.
Bretthauer M. Tidsskr Nor Laegeforen. 2024 Oct 22;144(14). doi: 10.4045/tidsskr.24.0525. Print 2024 Nov 26. PMID: 39605158 Free article. Norwegian. No abstract available.
Level 1
Performance of Faecal Immunochemical Testing for Colorectal Cancer Screening at Varying Positivity Thresholds.
Randel KR, Botteri E, de Lange T, Schult AL, Eskeland SL, El-Safadi B, Norvard ER, Bolstad N, Bretthauer M, Hoff G, Holme Ø. Aliment Pharmacol Ther. 2025 Jan;61(1):122-131. doi: 10.1111/apt.18314. Epub 2024 Oct 7. PMID: 39373173 Free PMC article. Clinical Trial.
Level 2 Journal Impact Factor 6.6
Om forhåndssamtaler, retningslinjer og randomisering.
Kalager M. Tidsskr Nor Laegeforen. 2024 Nov 1;144(13). doi: 10.4045/tidsskr.24.0539. Print 2024 Nov 5. PMID: 39498648 Free article. Norwegian. No abstract available.
Level 1
Creating a standardized tool for the evaluation and comparison of artificial intelligence-based computer-aided detection programs in colonoscopy: a modified Delphi approach.
Gadi SRV, Mori Y, Misawa M, East JE, Hassan C, Repici A, Byrne MF, von Renteln D, Hewett DG, Wang P, Saito Y, Matsubayashi CO, Ahmad OF, Sharma P, Gross SA, Sengupta N, Mansour N, Cherubini A, Dinh NN, Xiao X, Mountney P, González-Bueno Puyal J, Little G, LaRocco S, Conjeti S, Seibt H, Zur D, Shimada H, Berzin TM, Glissen Brown JR. Gastrointest Endosc. 2024 Nov 26:S0016-5107(24)03752-0. doi: 10.1016/j.gie.2024.11.042. Online ahead of print. PMID: 39608592
Level 1 Journal Impact Factor 6.7
Association of tea and coffee consumption and biliary tract cancer risk: The Biliary Tract Cancers Pooling Project.
Huang YH, Loftfield E, Argirion I, Adami HO, Albanes D, Chan AT, Fedirko V, Fraser GE, Freedman ND, Giles GG, Hartge P, Katzke V, Knutsen SF, Lacey J Jr, Liao LM, Luo J, Milne RL, O'Brien KM, Peters U, Poynter JN, Purdue MP, Robien K, Sandin S, Sandler DP, Setiawan VW, Kang JH, Simon TG, Sinha R, VoPham T, Weinstein SJ, White E, Zhang X, Zhu B, McGlynn KA, Campbell PT, Lee MH, Koshiol J. Hepatology. 2024 Jun 1;79(6):1324-1336. doi: 10.1097/HEP.0000000000000748. Epub 2023 Dec 29. PMID: 38758104
Level 2 Impact Factor 13.0
BMI and breast cancer risk around age at menopause.
Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. Cancer Epidemiol. 2024 Apr;89:102545. doi: 10.1016/j.canep.2024.102545. Epub 2024 Feb 19. PMID: 38377945
Level 2 Impact Factor 3.7
Artificial Intelligence to Predict the Risk of Lymph Node Metastasis in T2 Colorectal Cancer.
Ichimasa K, Foppa C, Kudo SE, Misawa M, Takashina Y, Miyachi H, Ishida F, Nemoto T, Lee JWJ, Yeoh KG, Paoluzzi Tomada E, Maselli R, Repici A, Terracciano LM, Spaggiari P, Mori Y, Hassan C, Spinelli A; early CRC group. Ann Surg. 2024 Nov 1;280(5):850-857. doi: 10.1097/SLA.0000000000006469. Epub 2024 Jul 30. PMID: 39077765
Level 2 Impact Factor 7.9
Computer-aided diagnosis for the resect-and-discard strategy for colorectal polyps: a systematic review and meta-analysis.
Hassan C, Rizkala T, Mori Y, Spadaccini M, Misawa M, Antonelli G, Rondonotti E, Dekker E, Houwen BBSL, Pech O, Baumer S, Li JW, von Renteln D, Haumesser C, Maselli R, Facciorusso A, Correale L, Menini M, Schilirò A, Khalaf K, Patel H, Radadiya DK, Bhandari P, Kudo SE, Sultan S, Vandvik PO, Sharma P, Rex DK, Foroutan F, Repici A; CADx analysis study group. Lancet Gastroenterol Hepatol. 2024 Nov;9(11):1010-1019. doi: 10.1016/S2468-1253(24)00222-X. Epub 2024 Sep 17. PMID: 39303733
Level 2 Impact Factor 30.9
Artificial intelligence for a rare disease.
Mori Y. Endoscopy. 2024 Dec 13. doi: 10.1055/a-2487-1252. Online ahead of print.PMID: 39672188 No abstract available.
Level 2 Journal Impact Factor 11.5
The prospective validation of a scoring system to assess mucosal cleanliness during EGD.
Romańczyk M, Ostrowski B, Lesińska M, Wieszczy-Szczepanik P, Pawlak KM, Kurek K, Wrońska E, Kozłowska-Petriczko K, Waluga M, Romańczyk T, Wosiewicz P, Bugajski M, Hartleb M, Kaminski MF, Sharma P. Gastrointest Endosc. 2024 Jul;100(1):27-35. doi: 10.1016/j.gie.2024.01.012. Epub 2024 Jan 11. PMID: 38215856
Level 1 Journal Impact Factor 6.7
QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopy.
Antonelli G, Libanio D, De Groof AJ, van der Sommen F, Mascagni P, Sinonquel P, Abdelrahim M, Ahmad O, Berzin T, Bhandari P, Bretthauer M, Coimbra M, Dekker E, Ebigbo A, Eelbode T, Frazzoni L, Gross SA, Ishihara R, Kaminski MF, Messmann H, Mori Y, Padoy N, Parasa S, Pilonis ND, Renna F, Repici A, Simsek C, Spadaccini M, Bisschops R, Bergman JJGHM, Hassan C, Dinis Ribeiro M. Gut. 2024 Dec 10;74(1):153-161. doi: 10.1136/gutjnl-2024-332820.PMID: 39406471
Level 2 Journal Impact Factor 23.1
Computer-aided detection for colorectal neoplasia in randomized and non-randomized studies.
Mori Y, Patel HK, Repici A, Rex DK, Sharma P, Hassan C. Endosc Int Open. 2024 Apr 23;12(4):E598-E599. doi: 10.1055/a-2295-2177. eCollection 2024 Apr. PMID: 38654966 Free PMC article. No abstract available.
Level 1 Impact Factor 2.2
Consensus statements on the current landscape of artificial intelligence applications in endoscopy, addressing roadblocks, and advancing artificial intelligence in gastroenterology.
ASGE AI Task Force; Parasa S, Berzin T, Leggett C, Gross S, Repici A, Ahmad OF, Chiang A, Coelho-Prabhu N, Cohen J, Dekker E, Keswani RN, Kahn CE, Hassan C, Petrick N, Mountney P, Ng J, Riegler M, Mori Y, Saito Y, Thakkar S, Waxman I, Wallace MB, Sharma P. Gastrointest Endosc. 2025 Jan;101(1):2-9.e1. doi: 10.1016/j.gie.2023.12.003. Epub 2024 Apr 17. PMID: 38639679
Level 1 Journal Impact Factor 6.7
Cost-Effectiveness for Artificial Intelligence in Colonoscopy.
Halvorsen N, Mori Y. Gastrointest Endosc Clin N Am. 2025 Apr;35(2):401-405. doi: 10.1016/j.giec.2024.10.008. Epub 2024 Nov 28. PMID: 40021236 Review.
Level 1 Journal Impact Factor 6.7
Advancing patient-centered care: Recent developments in UEG's patient relations.
Burra P, Amil Dias J, Torres J, Botos A, Acedo P, Bertelsen B, Bretthauer M, Carboni A, Dugic A, Fracasso P, Koltai T, Leone S, Maravic Z, Matysiak-Budnik T, McColaugh L, Mishkovikj M, Wickramasinghe K, van Leerdam M. United European Gastroenterol J. 2024 Jul;12(6):816-818. doi: 10.1002/ueg2.12607. Epub 2024 Jun 12. PMID: 38867386 Free PMC article.
Level 1 Journal Impact Factor 5.8
Fitting a progressive three-state colorectal cancer model to interval-censored surveillance data under outcome-dependent sampling using a weighted likelihood approach.
Akwiwu EU, Klausch T, Jodal HC, Carvalho B, Løberg M, Kalager M, Berkhof J, Coupé VMH. Am J Epidemiol. 2024 Aug 30: kwae307. doi: 10.1093/aje/kwae307. Online ahead of print. PMID: 39214647
Level 2 Journal Impact Factor 5.0
Dysbiosis of the Upper Gastrointestinal Tract in Head-and-Neck Cancer Survivors: A Pilot Study Using the Capsule Sponge Device.
Zeber-Lubecka N, Kulecka M, Dabrowska M, Kluska A, Piątkowska M, Turkot MH, Pilonis ND, Yusuf A, Nowicki-Osuch K, Mikula M, Ostrowski J. Cancers (Basel). 2024 Oct 18;16(20):3528. doi: 10.3390/cancers16203528. PMID: 39456621 Free PMC article.
Level 1 Impact Factor 4.5
Mortality and rate of hospitalization stratified by patients' BMI in a colonoscopy screening - a cross sectional analysis of data from Polish Colonoscopy Screening Platform.
Spychalski P, Wieszczy P, Połomska K, Kobiela J, Regula J, Kaminski MF, Pilonis N. Scand J Gastroenterol. 2024 Nov;59(11):1259-1264. doi: 10.1080/00365521.2024.2410795. Epub 2024 Oct 4. PMID: 39363857
Level 1 Journal Impact Factor 1.6